Clinical Trial Update: Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes

View source ↗

Summary

This clinical trial update describes using the FibroTouch device to screen for advanced liver fibrosis in patients with nonalcoholic fatty liver disease and und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Type 2 Diabetes Mellitus, Nonalcoholic Fatty Liver Disease (NAFLD) | Status: UNKNOWN